We are live on ! Find out more
CNMD icon

CONMED

236 hedge funds and large institutions have $1.21B invested in CONMED in 2026 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 98 increasing their positions, 73 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more call options, than puts

Call options by funds: $3.78M | Put options by funds: $1.38M

34% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 73

0.89% more ownership

Funds ownership: 109.73%110.62% (+0.89%)

11% less funds holding

Funds holding: 265236 (-29)

13% less capital invested

Capital invested by funds: $1.38B → $1.21B (-$174M)

42% less first-time investments, than exits

New positions opened: 33 | Existing positions closed: 57

Holders
236
Holders Change
-29
Holders Change %
-10.94%
% of All Funds
2.9%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
33
Increased
98
Reduced
73
Closed
57
Calls
$3.78M
Puts
$1.38M
Net Calls
+$2.41M
Net Calls Change
+$1.83M

CNMD Hedge Fund Activity: Q1 2026 in Review

236 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q1 2026, worth a combined $1.21B — down 13% from $1.38B a quarter earlier.

Sellers outnumbered buyers: 57 funds closed out of CNMD and 33 opened new positions — a net loss of 24 holders — while 73 trimmed existing stakes and 98 added.

The largest buyer was Two Sigma Investments, adding an estimated $20.8M. The largest seller was Wasatch Advisors, exiting entirely with an estimated $23.3M sold.

  • 236 institutional investors held CONMED (CNMD) as of Q1 2026, down from 265 in Q4 2025.
  • Funds reported $1.21B of CONMED stock for Q1 2026, down 13% quarter-over-quarter.
  • 33 funds opened new CONMED positions in Q1 2026 and 57 closed out, a net change of -24 holders.
  • The largest CONMED buyer in Q1 2026 was Two Sigma Investments, an estimated $20.8M added.
  • The largest CONMED seller in Q1 2026 was Wasatch Advisors, an estimated $23.3M sold.

Based on aggregated 13F filings for Q1 2026.